financetom
Business
financetom
/
Business
/
BRIEF-Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Eiger Biopharmaceuticals And Amylyx Entered Into An Asset Purchase Agreement
Jun 21, 2024 2:06 PM

June 21 (Reuters) - Eiger Biopharmaceuticals Inc ( EIGRQ ):

* COMPANY AND AMYLYX ENTERED INTO AN ASSET PURCHASE

AGREEMENT

* AMYLYX AGREED TO BUY ALL OF CO'S RIGHTS, TITLE,INTERESTS

IN

ASSETS,INTERESTS USED IN DEVELOPMENT,

MANUFACTURE,COMMERCIALIZATION OF AVEXITIDE

* ASSET PURCHASE AGREEMENT FOR $35.1 MILLION, PLUS AGGREGATE

AMOUNT OF DETERMINED CURE COSTS AND ASSUMED LIABILITIES

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved